{"id":955320,"date":"2026-07-24T02:48:21","date_gmt":"2026-07-24T02:48:21","guid":{"rendered":"https:\/\/www.europesays.com\/us\/955320\/"},"modified":"2026-07-24T02:48:21","modified_gmt":"2026-07-24T02:48:21","slug":"allergy-medication-sold-nationwide-recalled-for-potentially-life-threatening-mix-up-with-wrong-pills-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/955320\/","title":{"rendered":"Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills"},"content":{"rendered":"

(Gray News) \u2014 An over-the-counter allergy medication sold nationwide is being recalled<\/a> for a mix-up with another medication that could potentially be life-threatening.<\/p>\n

Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets, an antihistamine commonly sold as a generic version of Zyrtec.<\/p>\n

The recall was announced Saturday.<\/p>\n

According to the FDA, the recall includes bottles of 5-mg allergy tablets.<\/p>\n

\"AccordingAccording to the FDA, the recall includes bottles of 5-mg allergy tablets.(FDA)<\/p>\n

The recalled medication has identifying lot numbers printed on the sides of the bottles. For a list of exact lot numbers included in this recall, visit the FDA\u2019s website<\/a>.<\/p>\n

The bottles may be contaminated with ranitidine, formerly known as the brand name Zantac. The medication is used to treat heartburn, ulcers and indigestion.<\/p>\n

The FDA said the problem was found by a pharmacy technician who was counting the allergy tablets. The technician noticed the wrong-colored pills in the bottles, which prompted the recall.<\/p>\n

For people with hypersensitivity to ranitidine, taking this medication could potentially cause life-threatening reactions, including anaphylaxis.<\/p>\n

To date, there have been no reports of illnesses associated with this recall.<\/p>\n

The recalled medication was sold nationwide at several retailers.<\/p>\n

Anyone with questions about this recall can contact Rising Pharma Holdings Inc. at 1-844-874-7464 from 8 a.m. to 5 p.m. ET Monday through Friday, or email pv@risingpharma.com<\/a> or qa@risingpharma.com<\/a>.<\/p>\n

Adverse reactions to taking the recalled medication can be reported to the FDA online<\/a>. You are also encouraged to call your doctor.<\/p>\n

Copyright 2026 Gray Local Media, Inc. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"(Gray News) \u2014 An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…\n","protected":false},"author":3,"featured_media":955321,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[14208,71866,329893,384122,384121,151,384119,210,25283,1060,226282,177301,376105,22749,358213,87097,384120,67,132,68,384123,384118],"class_list":["post-955320","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-allergy","tag-allergy-medication","tag-antihistamine","tag-bottles","tag-cetirizine-hydrochloride-tablets","tag-fda","tag-generic-zyrtec","tag-health","tag-heartburn","tag-medication","tag-over-the-counter","tag-pills","tag-ranitidine","tag-recall","tag-recalled","tag-stomach-acid","tag-unique-pharmaceutical-laboratories","tag-united-states","tag-unitedstates","tag-us","tag-zantac","tag-zyrtec"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116972678674011347","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/955320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=955320"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/955320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/955321"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=955320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=955320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=955320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}